AI Marketing Company
AI Marketing Company
Ketamine Therapy
Patients researching ketamine for depression, PTSD, or chronic pain do more due diligence before booking than almost any other category on this list — safety protocols, provider credentials, and what a session actually involves all get scrutinized closely, and thin content gets filtered out immediately by patients and AI systems alike.
Why AI-Powered, Specifically
Ketamine therapy occupies an unusual position: it’s an FDA-approved anesthetic being used off-label (or, for esketamine/Spravato, on-label) for treatment-resistant depression, PTSD, and certain chronic pain conditions, and patients researching it are typically aware they’re considering something that sounds unusual or even alarming to people unfamiliar with the evidence. That means the research phase is unusually careful — patients read about medical supervision, monitoring during infusion, who administers it (an anesthesiologist, psychiatrist, or nurse under physician supervision), and what happens if something goes wrong, before they’ll even consider calling. AI systems answering safety-related questions in this space are correspondingly cautious, and they favor sources that address safety directly and specifically rather than glossing over it.
Because ketamine therapy is still relatively unfamiliar to much of the public compared to something like acupuncture, a meaningful share of the content job is educational: what ketamine therapy actually is, how it differs from illicit use, what a typical protocol and course of treatment looks like, and what the realistic expectations are. Practices that treat this education as central to their content, rather than assuming patients arrive already informed, convert a more hesitant but ultimately larger pool of researchers.
What We Build
AI visibility, ads, your website, and follow-up — built around the supervision and safety detail this audience looks for first.
Provider credentials and medical supervision need to be explicit and prominent: who is physically present during an infusion, what their qualifications are (anesthesiologist, psychiatrist, physician-supervised nurse), and what monitoring occurs throughout the session. This is the single most common question we see underserved on ketamine clinic websites, and it’s the first thing a careful researcher is looking for.
Distinguishing on-label esketamine (Spravato) from off-label IV or IM ketamine, and being precise about which your clinic offers and why, matters both for accuracy and because patients researching the space have often encountered this distinction already and will trust a clinic that addresses it directly more than one that blurs the two together.
Realistic, non-overstated framing of outcomes performs better than aggressive “breakthrough” language in this category. Patients considering ketamine therapy have frequently tried multiple prior treatments without success and are wary of anything that sounds like a miracle-cure pitch; content that’s honest about what a typical course of treatment involves, what response rates look like in general terms, and what happens if it doesn’t work builds more credibility than optimistic marketing copy.
Ketamine Therapy Questions
Yes, for off-label IV/IM ketamine administered by a licensed physician as part of legitimate medical practice, and on-label for esketamine (Spravato) when prescribed and administered per FDA REMS requirements. What matters for both compliance and trust is being accurate about which you offer, avoiding language that overstates guaranteed outcomes, and being explicit about the medical supervision involved.
In our experience, safety and supervision questions come first for a meaningful share of this audience, often before pricing. Many patients researching ketamine therapy are cautious by nature about the treatment itself — clear content about who monitors the infusion and what protocols are in place tends to move a hesitant researcher toward booking a consultation faster than pricing information alone.
It carries an extra layer of both medical-safety detail and public unfamiliarity to work through. A typical psychiatry practice can generally assume the patient understands what a psychiatrist does; a ketamine clinic usually needs to explain the treatment itself, the safety protocol, and the difference between medical use and the substance’s other associations, before it can even get to why a patient should choose this specific clinic.
Because this category involves a genuine medical screening process (not every patient is a candidate, and a physician consultation is a real clinical step, not just a sales call), content that sets accurate expectations about that process — what the screening involves, what disqualifies a candidate, how many sessions a typical course involves — reduces both wasted consultations and patient anxiety about what they’re walking into.
We also build content addressing cost and insurance directly, since ketamine therapy for depression is frequently not covered by insurance (Spravato is more often covered than IV ketamine) and sticker shock at the consultation stage is a common, avoidable reason patients drop off after expressing initial interest.
No templates — we review what’s actually costing you patients before building anything.
Prefer to talk? (805) 694-5042